Findings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Nicholas Wrigley
Advertisement
Articles by Nicholas Wrigley
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata
2
Tremfya Meets Primary, Major Secondary Endpoints in Phase 4 STAR Study of Axial PsA
3
Alopecia Areata Awareness Month: 2026 in Review
4
From Mechanism to Management: Navigating Male Pattern Hair Loss and New Topical Therapies
5